Table 1.
Individual 1 | Individual 2 | Individual 3 | Individual 4 | Individual 5 | Individual 6 | Individual 7 | Individual 8 | Individual 9 | |
---|---|---|---|---|---|---|---|---|---|
SEPHS1 variant (NM_012247.4) | c.1111C>T | c.1111C>T | c.1111C>T | c.1112G>A | c.1112G>A | c.1112G>A | c.1111C>G | c.1111C>G | c.1054T>G |
Exon | exon 9 | exon 9 | exon 9 | exon 9 | exon 9 | exon 9 | exon 9 | exon 9 | exon 9 |
Protein | p.Arg371Trp | p.Arg371Trp | p.Arg371Trp | p.Arg371Gln | p.Arg371Gln | p.Arg371Gln | p.Arg371Gly | p.Arg371Gly | p.Trp352Gly |
Inheritance | de novo | de novo | unknown | de novo | de novo | de novo | de novo | de novo | de novo |
PROVEAN (cutoff 2.5) | −3.75 | −3.75 | −3.75 | −1.15 | −1.15 | −1.15 | −3.65 | −3.65 | −10.49 |
GnomAD frequency | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reported CNV and SNVs | none reported | none reported | CMA: gain of chr13q14.1 (VUS, unknown inheritance)a | none reported | none reported | CMA: gain of chr3p25.3 (VUS, maternally inherited)a | de novo VUS in SRCAP, NM_006662.2: c.3833C>A (p.Ser1278∗)29 | none reported | heteroplasmic variant in MT-TL2; heterozygous VUS RAPSNa |
ACMG criteria applied33 | internal criteria, PM2, PP3 | internal criteria, PM2, PP3 | internal criteria, PM2, PP3 | internal criteria, PS2, PM2, BP4 | internal criteria, PS2, PM2, BP4 | internal criteria, PS2, PM2, BP4 | internal criteria, PM2, PP3 | internal criteria, PM2, PP3 | PS2, PS3, PM2, PP3 |
ACMG Class | PATH | PATH | PATH | PATH | PATH | PATH | PATH | PATH | PATH |
ClinVar accession | SCV002103293 .1 | SCV002103293.1 | SCV002103293.1 | SCV002103295.1 | SCV002103295.1 | SCV002103295.1 | SCV002103294.2 | SCV002103294.2 | SCV002103296.1 |
CMA, chromosomal microarray
No HGVS notation available